Vitamin Shoppe Inc (NYSE:VSI)’s share price traded up 8% during mid-day trading on Monday . The stock traded as high as $4.13 and last traded at $4.04. 1,198,600 shares changed hands during trading, an increase of 123% from the average session volume of 537,510 shares. The stock had previously closed at $3.74.

Several equities analysts have recently issued reports on the company. Zacks Investment Research raised Vitamin Shoppe from a “hold” rating to a “buy” rating and set a $5.75 target price on the stock in a research note on Thursday, May 16th. ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, March 15th.

The company has a quick ratio of 0.16, a current ratio of 1.14 and a debt-to-equity ratio of 2.36. The stock has a market cap of $89.72 million, a price-to-earnings ratio of 15.54 and a beta of 1.68.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings results on Wednesday, May 8th. The specialty retailer reported $0.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.03). Vitamin Shoppe had a net margin of 0.33% and a return on equity of 4.64%. The firm had revenue of $283.33 million for the quarter. On average, equities analysts forecast that Vitamin Shoppe Inc will post 0.55 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Investors Research Corp bought a new stake in shares of Vitamin Shoppe during the first quarter valued at approximately $34,000. Optimum Investment Advisors bought a new stake in shares of Vitamin Shoppe during the first quarter valued at approximately $35,000. Oregon Public Employees Retirement Fund bought a new stake in shares of Vitamin Shoppe during the fourth quarter valued at approximately $28,000. Quantamental Technologies LLC bought a new stake in shares of Vitamin Shoppe during the fourth quarter valued at approximately $39,000. Finally, Macquarie Group Ltd. boosted its position in shares of Vitamin Shoppe by 114.0% during the fourth quarter. Macquarie Group Ltd. now owns 10,136 shares of the specialty retailer’s stock valued at $48,000 after purchasing an additional 5,400 shares in the last quarter. Institutional investors own 88.97% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.watchlistnews.com/vitamin-shoppe-vsi-trading-8-higher/3030531.html.

Vitamin Shoppe Company Profile (NYSE:VSI)

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Featured Story: Real Estate Investment Trust (REIT) ETF

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.